---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-241416"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2025-10-16T23:59:59+00:00"
generated_at: "2026-05-17T03:31:57.499238+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology increases inducement stock option plan by 750,000 shares to 3.25M total

## Summary
- Board approved amendment to 2023 Inducement Option Plan, adding 750,000 shares for total of 3,250,000 shares.
- Plan reserved exclusively for nonstatutory stock options to new employees as inducement material to hire.
- Amendment approved without stockholder approval per Nasdaq Rule 5635(c)(4).
- Plan administered by independent directors or independent compensation committee.

## SEC filing metadata
- accession: 0001193125-25-241416
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2025-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312525241416/0001193125-25-241416-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312525241416/d20988d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-241416
- JSON: https://secwatch.observer/filing/0001193125-25-241416.json
- Plain text: https://secwatch.observer/filing/0001193125-25-241416.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.